Precision Medicine
Tailoring Treatments for Psychiatric Patients
Neuropharmagen® is a pharmacogenomics-based precision medicine platform especially developed for psychiatry. It helps optimize the pharmacological treatment based on the patient’s genetic profile, drug-drug interactions and lifestyle and clinico-physiological factors that influence the medication success.
Neuropharmagen® analyzes more that 60 polymorphisms in 26 genes to inform treatment decisions in psychiatry providing information for more that 60 psychoactive drugs most commonly used in disorders such as:
- Depression
- Schizophrenia
- Anxiety Disorder
- Bipolar Disorder
- Obsessive-Compulsive Disorder
- Attention Deficit Hyperactivity Disorder (ADHD)
- Epilepsy
Moreover, Neuropharmagen® allows the physician to integrate patient non-genetic characteristics in the report to get real time drug-drug and drug-factor alerts on top of the gene-drug alerts.
How does Neuropharmagen® help?
- Allows the physician to choose between different pharmacological alternatives for each individual patient
- Provides patient-specific dosing recommendations according to the patient’s metabolizer profile
- Helps anticipate information about pharmacological safety, identifying the risk of specific adverse effects
Neuropharmagen® has proven clinical utility, demonstrated by randomized clinical trials that have shown statistically significant improvements on both efficacy and tolerability when compared with treatment as usual.
